Biotek-snakken — Oktober 2024
-
Xbrane i aktiva avtalsförhandlingar kring Xdivane - fått första icke-bindande förslagen för XB003
I dag kl. 08:37 ∙ Finwire
Bioteknikbolaget Xbrane Biopharma har ingått aktiva avtalsförhandlingar avseende Xdivane och fått de första icke-bindande förslagen för XB003. Det framgår av ett pressmeddelande. -
ARCTIC BIOSCIENCE: ABG nedgraderer aksjen fra kjøp til hold og massakrerer kursmålet til NOK 2,5 (17).
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind